A/Professor Sumaira Z. Hasnain
@sumaira_hasnain
#Immunologist #Molecular Bio | Group Lead @MaterResearch @UQMedicine | 🇵🇰🇬🇧living in 🇦🇺| Mum of 2 | Views own | #Equity #Diversity #Inclusion | she/her
ID:935432742900137984
http://hasnainlab.com 28-11-2017 08:58:40
2,0K Tweets
1,2K Followers
2,3K Following
Follow People
Happy #Ramadan to all observing! Let's be mindful of colleagues fasting in academia this month. Offer flexible work arrangements, schedule meetings outside of lunchtimes, and avoid food-centric events. Every bit helps! #diversity #inclusion #Australia
This #CountHerIn & #InvestInWomen theme for #IWD2024 hits close to home. At 14 yo I lost my inspiring Mom👇🏼, a clinician/researcher, which fuelled my passion for science. When we invest in women, we invest in a brighter future for all! #CountHerIn ✨ #notjusttoday
Artificial intelligence-assisted analysis of intracellular calcium dynamics allows for the rapid prediction of T cell specificity Science Advances Melichar Lab
science.org/doi/10.1126/sc…
L-26 and trigger skin autoinflammation via activation of keratinocytes and concurrent killing of skin microbiota with formation of IL-26–DNA complexes that stimulate TLR9 JExpMed Michel Gilliet Jeremy Di Domizio
doi.org/10.1084/jem.20…
Congratulations, TRI-based A/Prof A/Professor Sumaira Z. Hasnain from Mater Research for your collaborative work with UQ News Institute for Molecular Bioscience researchers on tackling antibiotic resistant bacteria - with potential to address the threat of UTIs, meningitis and sepsis. bit.ly/3T8yfXG
Really excited to present this work led by Nhu Nguyen at Institute for Molecular Bioscience in collaboration with A/Professor Sumaira Z. Hasnain Glen Ulett and Jana Vukovic.
Researchers at Institute for Molecular Bioscience have discovered why some E. coli bacteria cause severe disease and others don't.
Schembri Lab says a mutation helps affected bacteria spread in the body, a finding that could help fight antibiotic resistance.
Read more: brnw.ch/21wHci7 📸Adobe
Some E. coli bacteria cause severe diseases like sepsis and UTI while others don't.
Researchers have found a mutation in the cellulose making machinery of E. coli which may explain the difference between 'good' and 'bad' bacteria.
🔗 bit.ly/4bKYkn6
Schembri Lab
.Md Moniruzzaman, A/Professor Sumaira Z. Hasnain et al. suggest that, while IL-22–based therapeutics improve pathology in chronic disease, their use may increase susceptibility to viral infections. hubs.la/Q02kSHTZ0
In our Barrier Immunity collection: hubs.la/Q02kSGPV0
#KSBarrierReg24